CleanSpark Inc (CLSK)

Pretax margin

Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021 Sep 30, 2020
Earnings before tax but after interest (EBT) US$ in thousands -142,433 -131,303 -40,089 -8,229 -23,346
Revenue US$ in thousands 378,968 168,408 131,525 39,287 10,029
Pretax margin -37.58% -77.97% -30.48% -20.95% -232.78%

September 30, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $-142,433K ÷ $378,968K
= -37.58%

The pretax margin of CleanSpark Inc exhibits significant variability over the observed period from September 30, 2020, to September 30, 2024. In the fiscal year ending September 30, 2020, the company reported a markedly negative pretax margin of -232.78%, indicating substantial losses relative to its pre-tax earnings. This figure improved considerably in the subsequent year, with the margin reducing to -20.95% by September 30, 2021, reflecting a considerable reduction in losses as a proportion of pretax income.

However, the trend reversed in the following year, with the pretax margin worsening to -30.48% as of September 30, 2022, suggesting increased pre-tax losses or diminished profitability relative to revenue. The deterioration continued notably in the year ending September 30, 2023, as the pretax margin declined further to -77.97%, indicating a significant decline in pre-tax profitability or increased losses.

Most recently, the data for September 30, 2024, shows an improvement in pretax margin to -37.58%. Although this represents a positive change compared to the prior year, the margin remains substantially negative, indicating that the company continues to incur considerable pre-tax losses overall.

Overall, CleanSpark Inc's pretax margin has been consistently negative over the observed period, with periods of fluctuation reflecting changes in profitability or operational efficiency. Despite some improvements at times, the persistent negative margins suggest ongoing challenges in achieving pre-tax profitability.


Peer comparison

Sep 30, 2024

Company name
Symbol
Pretax margin
CleanSpark Inc
CLSK
-37.58%
Astrana Health Inc
ASTH
3.97%
Hims Hers Health Inc
HIMS
4.86%